NASDAQ
Dyne Therapeutics, Inc. (DYN) has a current ratio of 22.25x as of Monday, May 25, 2026. This represents a 117.63% increase compared to its 12-month average of 10.23x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.